Sentinel Diagnostics acquired Eureka srl Lab Division

We are glad to announce that Sentinel Diagnostics (Sentinel CH. SpA), focused for 40 years on the development and production of in vitro diagnostic kits for clinical chemistry, immunochemistry, fecal testing, and molecular diagnostics, extends its expertise and activities in the field of chromatographyand mass spectrometry through the acquisition of EUREKA s.r.l.- LAB DIVISION

“This acquisition supports our plan to become an important player in the IVD assays development and production. With the extended capabilities we’ll be able to provide clinical laboratory with a wider catalogue of assays, from high throughput core lab tests to the most advanced, specialistic second level assays”, says, dr. Marco Buonaguidi, Sentinel Diagnostics’ Head of Sales and Marketing

For further information about the acquisition, please  contact us at or Eureka Lab Division at 


EUREKA s.r.l.- LAB DIVISION is an Italian company based in Chiaravalle (AN) which has been operating in IVD chromatographic market for 25 years, developing, producing and commercializing the world’s largest range of ready-to-use diagnostic kits for HPLC, GC, GC-MS, LC-MS/MS applications in the fields of Special Clinical Chemistry, Therapeutic Drug Monitoring, Occupational Toxicology and Forensic Toxicology.

For further information, please visit Eureka Lab Division’s website:

 About Sentinel CH. SpA

Sentinel Diagnostics (Sentinel CH. SpA) is an innovative company that, through the development of its products, contributes to the growth of scientific knowledge and the improvement of people’s health in the diagnostic field. For 40 years, Sentinel Diagnostics, an Italian company based in Milan, has been developing and producing in vitro diagnostic devices for the most advanced Clinical Chemistry, Immunochemistry and Molecular Diagnostics platforms.

New Products



Our Products



WHAT some of our existing clients think

Thanks to Steroid Hormones Eureka Kit I can obtain now 17 steroids results in a unique chromatographic run.
Once I used to work with several immunochemical analytical platforms. Obviously this was more expensive for my lab, furthermore I wasn’t exactly satisfied with the results.
Now I am!

Prof. Dr. SARA HABIF, Ege University Izmir, Biochemistry lab.

In our laboratory we have followed a Research, Development and Point-of-Test of a New Analytical Method. It can provide all oncologists with a valid diagnostic tool to monitor and personalize Tamoxifene treatment.
Based on the epidemiological data and our laboratory experience, Tamoxifene and Endoxifene pharmacological monitoring should become a COMMON PRACTICE in order to guarantee a personalized and effective therapy for all patients.
Why not provide our analytical method to improve the life expectancy of patients and in some cases save their lives? 
This question has been answered by an Italian company sensitive to this specific problem that has decided to engineer the method in the form of ready-to-use KITS.
The Eureka Kit is Simple and Robust and includes everything needed to treat the biological sample and to triple-quadrupole mass spectrometry (LC-MS / MS) analysis.

Prof. MINOTTI GIORGIO, Dott. MENNA PIERANTONIO, UOS Farmacologia Clinica Laboratorio Farmaco-Tossicologia Assistenziale, Policlinico Universitario Campus Biomedico Roma

My colleagues and I are very happy to use the Eureka kit for urine VMA/5HIAA/ HVA because it is easy , simple and accurate.
We compared the results we got from this kit with the results by Electrochemical detection.
It is very comparable.
Now we use it in place of  more complicated electrochemical process.
YAN KANG XU M.D., Childrens Hospital Los Angeles